Future prospects for Antimicrobial peptide development: peptidomimetics and antimicrobial combinations

Vista senzilla d'ítem
dc.contributor.authorSierra Ortigosa, Josep Maria
dc.contributor.authorViñas, Miquel
dc.date.accessioned2026-02-17T08:36:49Z
dc.date.available2026-02-17T08:36:49Z
dc.date.issued2021-02-24
dc.date.updated2026-02-17T08:36:50Z
dc.description.abstractAntimicrobial resistance is widely recognized as one of the major challenges of public health worldwide, as infections by multidrug-resistant (MDR) bacteria have reached worrisome levels. Three levels of antibiotic resistance have been described [Citation1]: i) multi-resistance (resistance to at least three different families of antimicrobials), ii) extreme resistance (resistance to all antimicrobials except colistin) and iii) pan-drug resistance (resistance to all available antimicrobials).
dc.format.extent4 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec712741
dc.identifier.issn1746-0441
dc.identifier.pmid33626997
dc.identifier.urihttps://hdl.handle.net/2445/226948
dc.language.isoeng
dc.publisherInforma Healthcare
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1080/17460441.2021.1892072
dc.relation.ispartofExpert Opinion on Drug Discovery, 2021, vol. 16, num.6, p. 601-604
dc.relation.urihttps://doi.org/10.1080/17460441.2021.1892072
dc.rights(c) Informa Healthcare, 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.subject.classificationMedicaments antibacterians
dc.subject.classificationAnàlisi de pèptids
dc.subject.otherAntibacterial agents
dc.subject.otherAnalysis of peptides
dc.titleFuture prospects for Antimicrobial peptide development: peptidomimetics and antimicrobial combinations
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Miniatura
Nom:
240098.pdf
Mida:
530.3 KB
Format:
Adobe Portable Document Format
Descarregar

Col·leccions

Articles publicats en revistes (Patologia i Terapèutica Experimental)